SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories submits press release

12 Aug 2019 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed about submission of the press release pertaining to receipt of ANDA approval from USFDA for Unichem's Chlorthalidone Tablets USP, 25 mg and 50 mg. 

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

347.60 -3.25 (-0.93%)
20-Apr-2026 10:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.55
Dr. Reddys Lab 1235.85
Cipla 1236.15
Zydus Lifesciences 942.40
Lupin 2334.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×